NO953034L - Heterosykliske forbindelser og deres fremstilling og anvendelse - Google Patents

Heterosykliske forbindelser og deres fremstilling og anvendelse

Info

Publication number
NO953034L
NO953034L NO953034A NO953034A NO953034L NO 953034 L NO953034 L NO 953034L NO 953034 A NO953034 A NO 953034A NO 953034 A NO953034 A NO 953034A NO 953034 L NO953034 L NO 953034L
Authority
NO
Norway
Prior art keywords
preparation
heterocyclic compounds
indeno
pyrazine
dione
Prior art date
Application number
NO953034A
Other languages
English (en)
Norwegian (no)
Other versions
NO953034D0 (no
Inventor
Peter Faarup
Palle Jakobsen
Anker Steen Jorgensen
Henrik Klitgaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO953034D0 publication Critical patent/NO953034D0/no
Publication of NO953034L publication Critical patent/NO953034L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Liquid Crystal Substances (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO953034A 1993-02-02 1995-08-01 Heterosykliske forbindelser og deres fremstilling og anvendelse NO953034L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93122A DK12293D0 (da) 1993-02-02 1993-02-02 Heterocykliske forbindelser og deres fremstilling og anvendelse
PCT/DK1994/000050 WO1994018175A1 (fr) 1993-02-02 1994-02-01 Composes heterocycliques, leur preparation et leur utilisation

Publications (2)

Publication Number Publication Date
NO953034D0 NO953034D0 (no) 1995-08-01
NO953034L true NO953034L (no) 1995-09-29

Family

ID=8090000

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953034A NO953034L (no) 1993-02-02 1995-08-01 Heterosykliske forbindelser og deres fremstilling og anvendelse

Country Status (14)

Country Link
US (2) US5468748A (fr)
EP (1) EP0682657B1 (fr)
JP (1) JPH08508979A (fr)
AT (1) ATE160342T1 (fr)
AU (1) AU674205B2 (fr)
CA (1) CA2155355A1 (fr)
DE (1) DE69406907D1 (fr)
DK (1) DK12293D0 (fr)
FI (1) FI953666L (fr)
IL (1) IL108486A (fr)
NO (1) NO953034L (fr)
NZ (1) NZ261299A (fr)
WO (1) WO1994018175A1 (fr)
ZA (1) ZA94711B (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2717805B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Dérivés de 5H-indeno[1,2-b]pyrazine-2,3-dione, leur préparation et les médicaments les contenant .
FR2717812B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Indeno[1,2-e]pyrazine-4-ones, leur préparation et les médicaments les contenant.
FR2717813B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Dérivés d'imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant .
FR2743363A1 (fr) * 1996-01-10 1997-07-11 Rhone Poulenc Rorer Sa 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-a-ones substituees en position 2, leur preparation et les medicaments les contenant
US7637948B2 (en) 1997-10-10 2009-12-29 Senorx, Inc. Tissue marking implant
US8668737B2 (en) 1997-10-10 2014-03-11 Senorx, Inc. Tissue marking implant
US6270464B1 (en) * 1998-06-22 2001-08-07 Artemis Medical, Inc. Biopsy localization method and device
US6638234B2 (en) 1998-03-03 2003-10-28 Senorx, Inc. Sentinel node location and biopsy
US6758848B2 (en) 1998-03-03 2004-07-06 Senorx, Inc. Apparatus and method for accessing a body site
US6497706B1 (en) 1998-03-03 2002-12-24 Senorx, Inc. Biopsy device and method of use
US6875182B2 (en) * 1998-03-03 2005-04-05 Senorx, Inc. Electrosurgical specimen-collection system
US6161034A (en) 1999-02-02 2000-12-12 Senorx, Inc. Methods and chemical preparations for time-limited marking of biopsy sites
US6347241B2 (en) * 1999-02-02 2002-02-12 Senorx, Inc. Ultrasonic and x-ray detectable biopsy site marker and apparatus for applying it
US6540695B1 (en) 1998-04-08 2003-04-01 Senorx, Inc. Biopsy anchor device with cutter
US20020058882A1 (en) * 1998-06-22 2002-05-16 Artemis Medical, Incorporated Biopsy localization method and device
US6679851B2 (en) 1998-09-01 2004-01-20 Senorx, Inc. Tissue accessing and anchoring device and method
US20090030309A1 (en) * 2007-07-26 2009-01-29 Senorx, Inc. Deployment of polysaccharide markers
US7983734B2 (en) 2003-05-23 2011-07-19 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US6862470B2 (en) 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
US9820824B2 (en) 1999-02-02 2017-11-21 Senorx, Inc. Deployment of polysaccharide markers for treating a site within a patent
US20080039819A1 (en) * 2006-08-04 2008-02-14 Senorx, Inc. Marker formed of starch or other suitable polysaccharide
US8361082B2 (en) 1999-02-02 2013-01-29 Senorx, Inc. Marker delivery device with releasable plug
US6725083B1 (en) 1999-02-02 2004-04-20 Senorx, Inc. Tissue site markers for in VIVO imaging
US8498693B2 (en) 1999-02-02 2013-07-30 Senorx, Inc. Intracorporeal marker and marker delivery device
US7651505B2 (en) 2002-06-17 2010-01-26 Senorx, Inc. Plugged tip delivery for marker placement
US6575991B1 (en) 1999-06-17 2003-06-10 Inrad, Inc. Apparatus for the percutaneous marking of a lesion
CA2659484C (fr) 2000-11-20 2013-01-08 Senorx, Inc. Marqueurs de sites tissulaires pour imagerie in vivo
US20060036158A1 (en) 2003-11-17 2006-02-16 Inrad, Inc. Self-contained, self-piercing, side-expelling marking apparatus
US7125586B2 (en) * 2003-04-11 2006-10-24 Delphi Technologies, Inc. Kinetic spray application of coatings onto covered materials
US20050119562A1 (en) * 2003-05-23 2005-06-02 Senorx, Inc. Fibrous marker formed of synthetic polymer strands
US7877133B2 (en) 2003-05-23 2011-01-25 Senorx, Inc. Marker or filler forming fluid
US20050273002A1 (en) 2004-06-04 2005-12-08 Goosen Ryan L Multi-mode imaging marker
US9408592B2 (en) 2003-12-23 2016-08-09 Senorx, Inc. Biopsy device with aperture orientation and improved tip
US8360990B2 (en) 2004-12-16 2013-01-29 Senorx, Inc. Biopsy device with aperture orientation and improved tip
WO2006102183A2 (fr) * 2005-03-18 2006-09-28 Gatekeeper Systems, Inc. Systeme de communication bidirectionnel permettant de suivre les positions et les etats de vehicules a roues
US10357328B2 (en) 2005-04-20 2019-07-23 Bard Peripheral Vascular, Inc. and Bard Shannon Limited Marking device with retractable cannula
US9095325B2 (en) 2005-05-23 2015-08-04 Senorx, Inc. Tissue cutting member for a biopsy device
US7572236B2 (en) 2005-08-05 2009-08-11 Senorx, Inc. Biopsy device with fluid delivery to tissue specimens
US8317725B2 (en) 2005-08-05 2012-11-27 Senorx, Inc. Biopsy device with fluid delivery to tissue specimens
US8052658B2 (en) 2005-10-07 2011-11-08 Bard Peripheral Vascular, Inc. Drug-eluting tissue marker
US20080230001A1 (en) * 2006-02-23 2008-09-25 Meadwestvaco Corporation Method for treating a substrate
US8064987B2 (en) 2006-10-23 2011-11-22 C. R. Bard, Inc. Breast marker
EP3542748B1 (fr) 2006-12-12 2023-08-16 C. R. Bard, Inc. Marqueur de tissu de mode d'imagerie multiples
EP2101670B1 (fr) 2006-12-18 2013-07-31 C.R.Bard, Inc. Marqueur de biopsie présentant des propriétés d'imagerie générées in situ
MX2010005928A (es) * 2007-11-28 2010-06-15 Astellas Pharma Inc Agentes antihelminticos y su uso.
US8311610B2 (en) 2008-01-31 2012-11-13 C. R. Bard, Inc. Biopsy tissue marker
US9327061B2 (en) 2008-09-23 2016-05-03 Senorx, Inc. Porous bioabsorbable implant
CA2742765C (fr) 2008-12-30 2016-04-12 C.R. Bard Inc. Dispositif d'administration de marqueurs destine a placer des marqueurs dans des tissus
USD716450S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715942S1 (en) 2013-09-24 2014-10-21 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715442S1 (en) 2013-09-24 2014-10-14 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716451S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK146787A (da) * 1987-03-23 1988-09-24 Ferrosan Heterocykliske forbindelser, deres fremstilling og anvendelse
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
US5153195A (en) * 1988-12-22 1992-10-06 Novo Nordisk A/S Quinoxaline compounds and their preparation and use
DK716188D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
DK101290D0 (da) * 1990-04-24 1990-04-24 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK73091D0 (da) * 1991-04-22 1991-04-22 Novo Nordisk As Quinoxalinforbindelser, deres fremstilling og anvendelse
FR2717805B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Dérivés de 5H-indeno[1,2-b]pyrazine-2,3-dione, leur préparation et les médicaments les contenant .

Also Published As

Publication number Publication date
FI953666A0 (fi) 1995-08-01
IL108486A (en) 1998-01-04
ATE160342T1 (de) 1997-12-15
EP0682657B1 (fr) 1997-11-19
US5468748A (en) 1995-11-21
NZ261299A (en) 1997-02-24
DK12293D0 (da) 1993-02-02
DE69406907D1 (de) 1998-01-02
WO1994018175A1 (fr) 1994-08-18
FI953666A7 (fi) 1995-09-28
US5646146A (en) 1997-07-08
NO953034D0 (no) 1995-08-01
CA2155355A1 (fr) 1994-08-18
JPH08508979A (ja) 1996-09-24
FI953666L (fi) 1995-09-28
ZA94711B (en) 1995-08-02
AU674205B2 (en) 1996-12-12
IL108486A0 (en) 1994-05-30
AU5998694A (en) 1994-08-29
EP0682657A1 (fr) 1995-11-22

Similar Documents

Publication Publication Date Title
DE69406907D1 (de) 9H-INDENO[1,2-b]PYRAZIN-3(4H)-ONE UND 9H-INDENO[1,2-b]PYRAZINE-2,3(1H,4H)-DIONE UND IHRE HERSTELLUNG UND VERWENDUNG
WO1997035539A3 (fr) Pyridines et pyrimidines a fusion arylamino
CA2265672A1 (fr) Pyrazinones et triazinones ainsi que leurs derives
AU3131697A (en) Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
NO961173D0 (no) Nye pyrido(3,2-e)pyrazinoner med antiastmatisk virkning og fremgangsmåte for deres fremstilling
FI971953A0 (fi) Proteiinityrosiinikinaasin välittämää soluproliferaatiota inhiboivat 6-aryyli-pyrido(2,3-d)pyrimidiinit ja naftyridiinit
NO943456L (no) Eventuelt substituerte pyrido-[2,3-dÅ-pyrimidin-2,4-(1H,3H)-dioner og pyrido-[2,3-dÅpyrimidin-2-(1H,3H)-oner
GR3029561T3 (en) Pyrrolopyrimidines as crf antagonists.
AU3686393A (en) Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
WO2004043367A3 (fr) Composes heterocycliques fusionnes et leur utilisation
DE19875039I2 (de) Ungesaettigte Hydroxyalkylchinolinsaeuren als Leukotrien-Antagonisten
AU4859396A (en) 2,3-substituted pyridines for the treatment of inflammation
NO962059L (no) Antiarytmiske benzodiazepiner
ATE213245T1 (de) Triazolo(4,5-d)pyrimidinyl-derivate und ihre verwendung als medikamente
ES2063202T3 (es) Nuevas 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y -tionas y su uso en la prevencion o tratamiento del sida.
NO962717L (no) Diaryl-5,6-kondenserte, heterosykliske syrer som leukotrienantagonister
NO981383L (no) Benzyloksysubstituerte, kondenserte N-heterocykluser, fremgangsmåter for deres fremstilling og deres anvendelse som bradykininreseptorantagonister
DE69116788D1 (de) 4-substituierte Dihydropyrido [4,3-d] pyrimidine als Analgetika und entzündungshemmende Mittel zur topischen Anwendung bei der Behandlung von Hauterkrankungen
NO971261L (no) Kinoksalin-derivater nyttige innen terapi
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
PL309408A1 (en) Diaryl-5,6-condensed heterocyclic acids as leucotrenic antagonistic substances
AU639612B2 (en) Hydroxyalkylquinoline ether acids as leukotriene antagonists
EP0251094A3 (fr) Quinoxalinediones et quinoléinediones substituées
DK0609371T3 (da) Thienopyrazin-2,3-dioner og deres fremstilling og anvendelse
DK23392D0 (da) Heterocykliske forbindelser, deres anvendelse og fremstilling